GlassScriptPhysician profile
Sheena A Mehta
NPI 1518359587
$4,183.15
in general payments reported to CMS, 2019-2025
13 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $569 · 2022: $461 · 2023: $501 · 2024: $1,256 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,153.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,338.02 | 2021-2025 | |
| Pfizer INC. | $579.64 | 2023-2025 | |
| Scilex Pharmaceuticals INC. | $231.69 | 2024-2025 | |
| Lilly USA, LLC | $223.50 | 2021-2025 | Emgality |
| Teva Pharmaceuticals USA, INC. | $213.35 | 2022-2025 | Ajovy |
| Lundbeck LLC | $195.50 | 2021-2025 | Vyepti |
| Upsher-Smith Laboratories LLC | $103.13 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $82.03 | 2022 | |
| Axsome Therapeutics, INC. | $55.46 | 2025 | Symbravo |
| Tonix Medicines, INC. | $52.50 | 2025 | Zembrace Symtouch |
| Impel Pharmaceuticals INC. | $43.50 | 2023 | Trudhesa |
| Impel Pharmaceuticals LLC | $33.56 | 2025 | Trudhesa |
| Biohaven Pharmaceuticals, INC. | $31.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.